Anti-inflammatory Drug May Raise Diabetes Risk

Glucocorticoids (GCs) are one of the most commonly prescribed anti-inflammatories for conditions such as arthritis, asthma, allergies and adrenal insufficiency. GC treatment at high doses for a long duration is known to be associated with metabolic side-effects that may increase risk of diabetes and obesity but there are currently no studies examining the short-term effects of GCs at the more regularly prescribed, lower doses. As 2-3% of the UK population take GCs for conditions of varying severity, it is important to investigate whether these metabolic side-effects occur in lower dose, short-term therapy. https://www.technologynetworks.com/drug-discovery/news/anti-inflammatory-drug-may-raise-diabetes-risk-327101?utm_campaign=NEWSLETTER_TN_Breaking%20Science%20News&utm_source=hs_email&utm_medium=email&utm_content=79277245&_hsenc=p2ANqtz-_EHnBrfjKIc9quMqzjKDmErSCWF7Jh1s_HrRqdwTWz5Qk0DYTEC19bl9x4RJx2EF14hiBu5xRPVLNDi_RtNZIph1oN_g&_hsmi=79277245